Michael Clemens
Impact in
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Pancreatic and Hepatic Oncology Research
- Bone health and treatments
- Cancer Treatment and Pharmacology
- Cancer Research top 2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 55
- Cancer Treatment and Pharmacology 15
- Pancreatic and Hepatic Oncology Research 15
- HER2/EGFR in Cancer Research 14
- Colorectal Cancer Treatments and Studies 11
-
- Advanced Breast Cancer Therapies 12
- Gastric Cancer Management and Outcomes 8
- Co-authors
- Hans Dierck Waller (8 shared papers)Hermann Einsele (11 shared papers)H. Remmer (8 shared papers)Volker Heinemann (14 shared papers)Michaela Lehle (1 shared paper)A. Feyereislova (1 shared paper)Sergei Tjulandin (1 shared paper)Andrew Wardley (1 shared paper)
- Journals
- Journal of Clinical Oncology (23 papers)Annals of Oncology (7 papers)British Journal of Cancer (7 papers)Cancer Research (6 papers)European Journal of Cancer (5 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Michael Clemens
112 papers receiving 4.9k citations
Michael Clemens's Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 2.7k
- Cancer Research 738
- Pulmonary and Respiratory Medicine 1.1k
- Radiology, Nuclear Medicine and Imaging 567
- Biochemistry 152
Countries citing papers authored by Michael Clemens
This map shows the geographic impact of Michael Clemens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Clemens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Clemens more than expected).
Fields of papers citing papers by Michael Clemens
This network shows the impact of papers produced by Michael Clemens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Clemens. The network helps show where Michael Clemens may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Clemens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study Hit paper breakdown → | 2009 | 598 |
| 2 | Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer Hit paper breakdown → | 2006 | 535 |
| 3 | Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study Hit paper breakdown → | 2009 | 505 |
| 4 | Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials Hit paper breakdown → | 2012 | 428 |
| 5 | 2005 | 308 | |
| 6 | 1987 | 290 | |
| 7 | 2008 | 184 | |
| 8 | 2000 | 146 | |
| 9 | 2008 | 129 | |
| 10 | 2000 | 101 | |
| 11 | 1996 | 98 | |
| 12 | 1985 | 93 | |
| 13 | 2014 | 88 | |
| 14 | 2019 | 78 | |
| 15 | 2003 | 78 | |
| 16 | 2012 | 77 | |
| 17 | 2014 | 68 | |
| 18 | 1990 | 62 | |
| 19 | 1998 | 59 | |
| 20 | 1991 | 55 |
About Michael Clemens
Michael Clemens is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Surgery, having authored 115 papers that have together received 5.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (23 papers), Cancer Treatment and Pharmacology (15 papers), Pancreatic and Hepatic Oncology Research (15 papers), HER2/EGFR in Cancer Research (14 papers), Advanced Breast Cancer Therapies (12 papers), Colorectal Cancer Treatments and Studies (11 papers), Cancer Genomics and Diagnostics (9 papers) and Gastric Cancer Management and Outcomes (8 papers). The work is most often cited by research in Oncology (2.7k citations), Cancer Research (738 citations), Pulmonary and Respiratory Medicine (1.1k citations), Radiology, Nuclear Medicine and Imaging (567 citations) and Biochemistry (152 citations). Michael Clemens has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Hans Dierck Waller, Hermann Einsele, H. Remmer, Volker Heinemann, Michaela Lehle, A. Feyereislova, Sergei Tjulandin, Andrew Wardley, John R. Mackey and Ashok K. Vaid. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.